In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development co-operation and finance.
Tables des matières:
- Acronyms and Abbreviations - Neglected and Emerging Infectious Diseases - Why It Is An Issue Now - What Are the Problems? - Why Is It in the Economic Interest of OECD Countries to Address these Problems?
- Present Policy Solutions Being Used to Address the Problems of Neglected Infectious Diseases - Moving Forward - Solutions and Next Steps - Annex A - Summaries of the High-Level Forum Preparatory Workshops - Annex B - The Basic Economics of Scaling Up Healthcare in Low-Income Settings - Annex C - OECD Country Policy Options for Increasing the Availability of Medicines for Neglected Diseases - Annex D - Improving the Access to Essential Medicines in Low-Income Countries